Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

Raphael J. Landovitz, Sue Li, Joseph J. Eron, Beatriz Grinsztejn, Halima Dawood, Albert Liu, Manya Magnus, Mina C. Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A. Marzinke, Susan H. Eshleman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R. Rinehart, David M. Margolis, Myron S. Cohen, Marybeth McCauley, Craig W. Hendrix